To explore the optimized concentration of AAV2-GFP for sparse transfection of retinal ganglion cells (RGCs) and optic nerve (ON), and to examine the changes of microglial morphology and distribution in the retina, optic nerve and chiasm after injection.
Methods
We defined the optimal concentration of AAV2-GFP for sparse labeling of RGCs and axons in WT mice. We further explored the changes of microglial morphology and distribution in the retina, optic nerve and chiasm after intravitreal injection in CX3CR1+/GFP mice.
Results
14 days after intravitreal injection of AAV2-GFP, live imaging of the retina showed that fundus fluorescence was very strong and dense at 2.16 × 1011 VG/retina, 2.16 × 1010 VG/retina, 2.16 × 109 VG/retina. RGCs were sparsely marked at a concentration 1:1000 (2.16 × 108 VG/retina) and fundus fluorescence was weak. The transfected RGCs and axons were unevenly distributed in the retina and significantly more RGCs were transfected near the injection site of AAV2-GFP compared to the other sites of the flat-mounted retina. Microglia density increased significantly in the retina and part of optic nerve, but not in the optic chiasm. The morphology of microglia was largely unchanged.
Conclusions
AAV2-GFP was highly efficient and the optimal concentration of sparsely labeled RGCs was 1:1000 (2.16 × 108 VG/retina). After intravitreal injection of AAV2-GFP, the number of microglia increased partly. The morphology of microglia was comparable.
FengGMellorRHBernsteinMKeller-PeckCNguyenQTWallaceM, et al.Imaging neuronal subsets in transgenic mice expressing multiple spectral variants of GFP. Neuron2000; 28(1): 41–51.
2.
PorreroCRubio-GarridoPAvendanoCClascaF. Mapping of fluorescent protein-expressing neurons and axon pathways in adult and developing Thy1-eYFP-H transgenic mice. Brain Res2010; 1345: 59–72.
3.
LuoXSalgueiroYBeckermanSRLemmonVPTsoulfasPParkKK. Three-dimensional evaluation of retinal ganglion cell axon regeneration and pathfinding in whole mouse tissue after injury. Exp Neurol2013; 247: 653–62.
4.
MartinKRKleinRLQuigleyHA. Gene delivery to the eye using adeno-associated viral vectors. Methods2002; 28(2): 267–75.
5.
Keller-PeckCRWalshMKGanWBFengGSanesJRLichtmanJW. Asynchronous synapse elimination in neonatal motor units: studies using GFP transgenic mice. Neuron2001; 31(3): 381–94.
ChenYSChungSSChungSK. Noninvasive monitoring of diabetes-induced cutaneous nerve fiber loss and hypoalgesia in thy1-YFP transgenic mice. Diabetes2005; 54(11): 3112–8.
8.
LiuHSJanMSChouCKChenPHKeNJ. Is green fluorescent protein toxic to the living cells?Biochem Biophys Res Commun1999; 260(3): 712–7.
9.
BuckinghamBPInmanDMLambertWOglesbyECalkinsDJSteeleMR, et al.Progressive ganglion cell degeneration precedes neuronal loss in a mouse model of glaucoma. J Neurosci2008; 28(11): 2735–44.
10.
CrishSDSappingtonRMInmanDMHornerPJCalkinsDJ. Distal axonopathy with structural persistence in glaucomatous neurodegeneration. Proc Natl Acad Sci U S A2010; 107(11): 5196–201.
11.
FernandezDCPasquiniLADorfmanDAldana MarcosHJRosensteinRE. Early distal axonopathy of the visual pathway in experimental diabetes. Am J Pathol2012; 180(1): 303–13.
12.
DorfmanDFernandezDCChianelliMMirandaMArandaMLRosensteinRE. Post-ischemic environmental enrichment protects the retina from ischemic damage in adult rats. Exp Neurol2013; 240: 146–56.
13.
PangJJLauramoreADengWTLiQDoyleTJChiodoV, et al.Comparative analysis of in vivo and in vitro AAV vector transduction in the neonatal mouse retina: effects of serotype and site of administration. Vision Res2008; 48(3): 377–85.
14.
HerrmannAKGrimmD. High-Throughput Dissection of AAV-Host Interactions: The Fast and the Curious. J Mol Biol2018; 430(17): 2626–40.
15.
BoyeSEBoyeSLLewinASHauswirthWW. A comprehensive review of retinal gene therapy. Mol Ther2013; 21(3): 509–19.
16.
Petrs-SilvaHDinculescuALiQDengWTPangJJMinSH, et al.Novel properties of tyrosine-mutant AAV2 vectors in the mouse retina. Mol Ther2011; 19(2): 293–301.
17.
KettenmannHHanischUKNodaMVerkhratskyA. Physiology of microglia. Physiol Rev2011; 91(2): 461–553.
18.
KarlstetterMScholzRRutarMWongWTProvisJMLangmannT. Retinal microglia: just bystander or target for therapy?Prog Retin Eye Res2015; 45: 30–57.
19.
NimmerjahnAKirchhoffFHelmchenF. Resting microglial cells are highly dynamic surveillants of brain parenchyma in vivo. Science2005; 308(5726): 1314–8.
20.
WakeHMoorhouseAJJinnoSKohsakaSNabekuraJ. Resting microglia directly monitor the functional state of synapses in vivo and determine the fate of ischemic terminals. J Neurosci2009; 29(13): 3974–80.
21.
JonasRAYuanTFLiangYXJonasJBTayDKEllis-BehnkeRG. The spider effect: morphological and orienting classification of microglia in response to stimuli in vivo. PLoS One2012; 7(2): e30763.
22.
ZhangYPengBWangSLiangYXYangJSoKF, et al.Image processing methods to elucidate spatial characteristics of retinal microglia after optic nerve transection. Sci Rep2016; 6: 21816.
23.
XiongWWuDMXueYWangSKChungMJJiX, et al.AAV cis-regulatory sequences are correlated with ocular toxicity. Proc Natl Acad Sci U S A2019; 116(12): 5785–94.
24.
HuYParkKKYangLWeiXYangQChoKS, et al.Differential effects of unfolded protein response pathways on axon injury-induced death of retinal ganglion cells. Neuron2012; 73(3): 445–52.
25.
WangQZhuangPHuangHLiLLiuLWebberHC, et al.Mouse gamma-Synuclein Promoter-Mediated Gene Expression and Editing in Mammalian Retinal Ganglion Cells. J Neurosci2020; 40(20): 3896–914.
26.
PangJChengMHaireSEBarkerEPlanellesVBlanksJC. Efficiency of lentiviral transduction during development in normal and rd mice. Mol Vis2006; 12: 756–67.
27.
YangLMiaoLLiangFHuangHTengXLiS, et al.The mTORC1 effectors S6K1 and 4E-BP play different roles in CNS axon regeneration. Nat Commun2014; 5: 5416.
28.
HastieESamulskiRJ. Adeno-associated virus at 50: a golden anniversary of discovery, research, and gene therapy success--a personal perspective. Hum Gene Ther2015; 26(5): 257–65.
29.
MacLarenREGroppeMBarnardARCottriallCLTolmachovaTSeymourL, et al.Retinal gene therapy in patients with choroideremia: initial findings from a phase 1/2 clinical trial. Lancet2014; 383(9923): 1129–37.
30.
YangYWangLBellPMcMenaminDHeZWhiteJ, et al.A dual AAV system enables the Cas9-mediated correction of a metabolic liver disease in newborn mice. Nat Biotechnol2016; 34(3): 334–8.
31.
ParkKKLiuKHuYSmithPDWangCCaiB, et al.Promoting axon regeneration in the adult CNS by modulation of the PTEN/mTOR pathway. Science2008; 322(5903): 963–6.
32.
MiaoLYangLHuangHLiangFLingCHuY. mTORC1 is necessary but mTORC2 and GSK3beta are inhibitory for AKT3-induced axon regeneration in the central nervous system. Elife2016; 5: e14908.
33.
HuY. The necessary role of mTORC1 in central nervous system axon regeneration. Neural Regen Res2015; 10(2): 186–8.
34.
WangQWuZZhangJFirrmanJWeiHZhuangZ, et al.A Robust System for Production of Superabundant VP1 Recombinant AAV Vectors. Mol Ther Methods Clin Dev2017; 7: 146–56.
35.
WuZAsokanASamulskiRJ. Adeno-associated virus serotypes: vector toolkit for human gene therapy. Mol Ther2006; 14(3): 316–27.
Gomez-NicolaDPerryVH. Microglial dynamics and role in the healthy and diseased brain: a paradigm of functional plasticity. Neuroscientist2015; 21(2): 169–84.
38.
MiyamotoAWakeHIshikawaAWEtoKShibataKMurakoshiH, et al.Microglia contact induces synapse formation in developing somatosensory cortex. Nat Commun2016; 7: 12540.
39.
PaolicelliRCBolascoGPaganiFMaggiLScianniMPanzanelliP, et al.Synaptic pruning by microglia is necessary for normal brain development. Science2011; 333(6048): 1456–8.
40.
WakselmanSBechadeCRoumierABernardDTrillerABessisA. Developmental neuronal death in hippocampus requires the microglial CD11b integrin and DAP12 immunoreceptor. J Neurosci2008; 28(32): 8138–43.
41.
HanischUKKettenmannH. Microglia: active sensor and versatile effector cells in the normal and pathologic brain. Nat Neurosci2007; 10(11): 1387–94.
42.
DavalosDGrutzendlerJYangGKimJVZuoYJungS, et al.ATP mediates rapid microglial response to local brain injury in vivo. Nat Neurosci2005; 8(6): 752–8.
43.
SaijoKGlassCK. Microglial cell origin and phenotypes in health and disease. Nat Rev Immunol2011; 11(11): 775–87.
44.
de HozRRamirezAIGonzalez-MartinRAjoyDRojasBSalobrar-GarciaE, et al.Bilateral early activation of retinal microglial cells in a mouse model of unilateral laser-induced experimental ocular hypertension. Exp Eye Res2018; 171: 12–29.
45.
RamirezAIde HozRFernandez-AlbarralJASalobrar-GarciaERojasBValiente-SorianoFJ, et al.Time course of bilateral microglial activation in a mouse model of laser-induced glaucoma. Sci Rep2020; 10(1): 4890.
46.
WalkerFRBeynonSBJonesKAZhaoZKongsuiRCairnsM, et al.Dynamic structural remodelling of microglia in health and disease: a review of the models, the signals and the mechanisms. Brain Behav Immun2014; 37: 1–14.
47.
HuXLiPGuoYWangHLeakRKChenS, et al.Microglia/macrophage polarization dynamics reveal novel mechanism of injury expansion after focal cerebral ischemia. Stroke2012; 43(11): 3063–70.
48.
ChenCChuSFAiQDZhangZGuanFFWangSS, et al.CKLF1 Aggravates Focal Cerebral Ischemia Injury at Early Stage Partly by Modulating Microglia/Macrophage Toward M1 Polarization Through CCR4. Cell Mol Neurobiol2019; 39(5): 651–69.
